Helmy Eltoukhy, Chief Executive Officer at Guardant Health, Inc. (GH), sold 157,320 shares at $72.05 ($11.4M) on 2019-05-14, disclosed to the SEC on 2019-05-16.
Open-market sale of $11.4M GH by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $72.05 | 24,532 | $1.8M | 15.5% |
| 2 | $72.05 | 24,532 | $1.8M | 15.5% |
| 3 | $72.47 | 54,128 | $3.9M | 34.5% |
| 4 | $72.47 | 54,128 | $3.9M | 34.5% |
| Total | $72.34 avg | 157,320 | $11.4M | 100% |
| Filing → |
| GH | SELL | 2025-09-11 | $35.7M | — | Filing → |
| GH | BUY | 2023-03-16 | $4.7M | — | Filing → |
| GH | BUY | 2021-11-23 | $17.7M | — | Filing → |